Kaplan-Meier failure curves for RSV-associated mortality stratified according to ISI-RSV risk group and antiviral therapy at the URTI stage. No deaths were observed in the low-risk group, regardless of whether they received antiviral therapy at the URTI stage; hence the 2 lines for this group overlap.